The UK Intellectual Property Office (UKIPO) is consulting on possible changes to the UK design framework with the aims of improving design validity, simplifying the regime, and protecting emerging forms of design.
READ MORE
The G1/23 ruling from the European Patent Office marked a pivotal shift in how marketed products are treated as prior art, redefining the principles of reproducibility and disclosure across Europe. Dehns has collaborated with international patent experts to provide a global perspective on the ruling.
READ MORE
The intersection between plant sciences and intellectual property (IP) rights (patents and plant variety rights) has been a thorny area for a number of years, particularly in Europe with respect to genetically-modified (GM) plants. In this insight, Biotechnology Partner, Kit Wilkins explores this area and the recent issue of a position paper from AIPPI.
READ MORE
Nera Innovations Ltd. (Nera), a patent holding company owned by Atlantic IP (a non-practising entity), has lost an infringement action against Xiaomi Communications Co., Ltd.; Xiaomi Inc.; Xiaomi Technology Netherlands B. V. and Xiaomi Technology Germany GmBH (Xiaomi).
READ MORE
This decision concerned an application for provisional measures, in particular an anti-anti-suit injunction (‘AASI’), by Avago Technologies International Sales Pte. Limited against the defendant Realtek Semiconductor Corporation
READ MORE
10x Genomics Inc. (10x Genomics) brought an infringement action against Curio Bioscience Inc. (Curio) accusing Curio of indirectly infringing claim 1, and directly infringing claim 14 of 10x’s patent EP 2 697 391 (‘the patent’) in their ‘Curio Seeker Spatial Mapping’ kits, sold in Germany, France and Sweden.
READ MORE
With the Supreme Court set to hear the appeal in Emotional Perception AI’s patent application next week, the UK patent profession eagerly awaits the outcome of the appeal.
READ MORE
Following last week’s historic third consecutive Ferrari outright win at the 24 hours of Le Mans, Dehns Technology, Software and Engineering Associate, Thomas Jeal reflects on another exciting event from this year’s race week: Toyota’s unveiling of their hydrogen combustion engine Hypercar Prototype, the GR LH2 Racing Concept.
READ MORE
Panasonic Holdings Corporation (Panasonic) brought an infringement action against Guangdong OPPO Mobile Telecommunications Corp Ltd and OROPE Germany GmBH (OPPO), accusing OPPO of infringing Panasonic’s patent EP 2 568 724 in their 4G-capable products including smartphones and smartwatches. Emily Dekker, Trainee Patent Attorney discusses this matter in more detail.
READ MORE
Huawei brought an action in the Munich local division against Netgear for infringement of EP3611989 in relation to various of its WiFi access point products. Huawei had declared EP’989 to be essential to the IEEE 802.11ax (“WiFi 6”) standard and so was obliged to offer a licence on Fair, Reasonable and Non-Discriminatory (FRAND) terms. However, no licence could be agreed.
READ MORE
On 1st May 2025, Phase 1 of the EUIPO’s design reform came into effect. Many of the changes brought about by this reform are motivated by a desire to align EU design law with the world around us, which is increasingly manifesting in digital forms.
READ MORE
Printing giants Hewlett-Packard (“HP”) brought a claim of infringement against French electronics wholesaler LAMA France (“LAMA”) before the Paris Local Division of the UPC at the end of last year, from which they came out (partially) victorious.
READ MORE
Implication of EPO decision on prior English court decision: Paul Harris, Head of Litigation at Dehns provides a case analysis of Vodafone Group PLC and ors v IPCom GmbH.
What better time to acknowledge the achievements of the women in our firm than the International day of Women and Girls in Science. In celebration of this day, our Senior Partner, Elizabeth Jones, discusses topics ranging from becoming a patent attorney to the importance of normalising the presence of women in STEM (Science, Technology, Engineering and Mathematics) fields.
In honour of International day of Women and Girls in Science, Dehns has interviewed a series of inspiring role models in our network.
Anne Ulvestad, CEO of Arctic Pharma AS, kindly opened up about her experiences in this industry, from her motivation for pursuing a career in STEM to her experience of barriers to entry.
Can adding the company name to a mark avoid infringement?: Lauren Palmer, Legal Assistant at Dehns provides a case analysis of Combe International v Dr Wolff
Arrow declaration misses its target: Paul Harris, Head of Litigation at Dehns, considers the extent to which the Patents Court will go in order to provide a “spin-off value” for one party, in the courts of another jurisdiction.
A balance must be struck between the competing interests of generic and innovator companies to ensure the healthcare system works at its best. At the moment, that longstanding balance has been disrupted by the Federal Circuit and the ripples are still being felt in the generics industry, even if the court has tried to take some of the sting out of its earlier actions.
In this episode of The IP Podcast, Senior Associate Daniel Rowe discusses a topic relating to the biotechnology and pharma industries: repurposed drugs and skinny labelling.
Tune in to hear Dan answer:
All these questions and more, answered in less than 20 minutes!
The contributions of both generic and innovator companies to our healthcare systems are essential, and a balance must be struck between their competing interests to ensure the system works at its best.
Read Neil Campbell’s latest thinking on how far a commercial product placed on the market becomes part of the state of the art. Neil will be speaking at LSPN in San Francisco on 1 November.
The purpose of patents is to drive innovation. However, many jurisdictions accept that a patent term of 20 years from filing is not always sufficient to compensate an innovator for the expense and risk of developing certain types of product. Many countries in Europe (including the UK despite its exit from the EU) have adopted an alternative approach to compensating for lost patent term. This new right is known as a “Supplementary Protection Certificate” (SPC) and although quite limited in scope, it can provide highly valuable protection since it comes into force at the expiry of the patent and is sharply focused on protecting the commercial produc
Subscribe here for updates on IP news, events and webinars.
|